{"id":506435,"date":"2020-09-10T19:30:02","date_gmt":"2020-09-10T19:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=506435"},"modified":"2020-09-10T19:30:02","modified_gmt":"2020-09-10T19:30:02","slug":"recombinant-dna-technology-market-size-2020-technology-advancement-industry-growth-swot-analysis-key-companies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/recombinant-dna-technology-market-size-2020-technology-advancement-industry-growth-swot-analysis-key-companies_506435.html","title":{"rendered":"Recombinant DNA Technology Market Size 2020, Technology Advancement, Industry Growth, SWOT Analysis, Key Companies"},"content":{"rendered":"
\"Recombinant<\/a><\/p>\n
\n
Recombinant DNA Technology Market <\/div>\n<\/div>\n<\/div>\n
Recombinant DNA Technology Market Research Report: By Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food & Agriculture, Health & Disease), End-User (Biotechnology Companies, Pharmaceuticals) \u2013 Forecast to 2023<\/div>\n

Recombinant DNA Technology Market <\/strong>Scenario <\/strong><\/p>\n

Market Research Future (MRFR) analyzed the global recombinant DNA technology market 2020 through the forecast period (between 2017 and 2023). As per MRFR assessment, the recombinant DNA technology market can rise at 6.9% CAGR in the analysis period. The COVID 19 has initiated extensive research in the field of genetics. A comprehensive analysis of the recombinant DNA technology market dynamics in the pandemic is offered in the report.<\/p>\n

Recombinant DNA technology is widely used in genetic modifications (GM). Genetically modified organisms and products are of superior quality. Resistance to certain harmful chemicals, better survival abilities in difficult conditions, and high productivity are some of such qualities. Thus, GM products, especially food, are highly adopted by people. A large populace of fitness conscious people is one of the high end-users of GM crops. These factors are observed to support the rise of the recombinant DNA technology market across the analysis period.<\/p>\n

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https:\/\/www.marketresearchfuture.com\/sample_request\/5845<\/a><\/strong><\/p>\n

The expanding biotechnology sector is another crucial end-user of recombinant DNA technology. Applied immunology, diagnostic tools, genomics, and pharmaceutical therapeutics are some of its applications. Moreover, renowned medical institutions have launched recombinant DNA treatment for diseases, such as leukaemia and neuropathies. These causes can boost the progress of the worldwide recombinant DNA technology market <\/p>\n

Recombinant DNA Technology Market Segmentation <\/strong><\/p>\n

The segment assessment of the recombinant DNA technology market is done by product, end-user, component, and application. <\/p>\n

The product type based segment of the recombinant DNA technology market are non-medical, and medical among others. The medical sub-segments are human protein, therapeutic agent, and vaccines. The non-medical segments are specialty chemicals, and biotech crops among others.<\/p>\n

The component based segment of the recombinant DNA technology market are cloning vector, and expression system among others. The expression system sub-segments are bacteria, mammalian, baculovirus or insect, and yeast among others. The cloning vector sub-segments are cosmid, plasmid, phage, Yeast Artificial Chromosome (YAC), Human Artificial Chromosome (HAC), and Bacterial Artificial Chromosome (BAC).<\/p>\n

The application based segment of the global recombinant DNA technology market are health and disease, food and agriculture, and environment among others.<\/p>\n

The end-user based segment of the recombinant DNA technology market<\/a><\/strong> are academic and government research institutes, biotechnology companies, and pharmaceuticals among others. <\/p>\n

Recombinant DNA Technology Market Regional Analysis <\/strong><\/p>\n

In North America, the recombinant DNA technology is observed to celebrate huge commercial success, which is observed to support the regional market rise. Over past few years, the increased resolution of issues in biotech ad biopharmaceutical industries by DNA recombination technology is observed. The application of the technology for biopesticides and mainly genetically modified crops to curb burden of chronic diseases among people can drive the regional market. Researches for the need to enhanced recombinant protein production capacity to boost biopharmaceuticals pipeline for the introduction of effective therapeutics by the regional government. This is observed to have a long-term benefit for North America market in the approaching years. Europe and APAC are expected to witness exponential rise in the market as early adoption of advanced medical technologies is observed. <\/p>\n

Recombinant DNA Technology Market Key Players <\/strong><\/p>\n

Eli Lilly and Company (U.S.), Amgen Inc. (U.S.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Genscript Biotech (U.S.), New England Biolabs (U.S.), Sanofi S.A. (France), Cibus (U.S.), Biocon Limited (India), Novo Nordisk A\/S (Denmark), Biogen Inc. (U.S.), Monsanto Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Horizon Discovery Group PLC (U.S.), GlaxoSmithKline plc (UK), Pfizer Inc. (U.S.), Profacgen (U.S.), and Boehringer Ingelheim (Germany) are some renowned names in the global recombinant DNA technology market that are profiled by MRFR.<\/p>\n

TABLE OF CONTENT
<\/strong><\/p>\n

Chapter 1. Report Prologue
<\/strong><\/p>\n

Chapter 2. Market Introduction
<\/strong><\/p>\n

2.1 Definition<\/p>\n

2.2 Scope Of The Study<\/p>\n

2.2.1 Research Objective<\/p>\n

2.2.2 Assumptions<\/p>\n

2.2.3 Limitations<\/p>\n

Chapter 3. Research Methodology
<\/strong><\/p>\n

3.1 Introduction<\/p>\n

3.2 Primary Research<\/p>\n

3.3 Secondary Research<\/p>\n

3.4 Market Size Estimation<\/p>\n

Chapter 4. Market Dynamics
<\/strong><\/p>\n

4.1 Drivers<\/p>\n

4.2 Restraints<\/p>\n

4.3 Opportunities<\/p>\n

4.4 Challenges<\/p>\n

4.5 Macroeconomic Indicators<\/p>\n

4.6 Technology Trends & Assessment<\/p>\n

Chapter 5. Market Factor Analysis<\/strong><\/p>\n

…TOC Continued<\/strong><\/p>\n

LIST OF TABLES
<\/strong><\/p>\n

Table 1 Recombinant DNA Technology Industry Synopsis, 2017–2023<\/p>\n

Table 2 Recombinant DNA Technology Market Estimates & Forecast, 2017–2023, (USD Million)<\/p>\n

Table 3 Recombinant DNA Technology Market, By Region, 2017–2023, (USD Million)<\/p>\n

Table 4 Recombinant DNA Technology Market, By Product, 2017–2023, (USD Million)<\/p>\n

Table 5 Recombinant DNA Technology Market, By Component, 2017–2023, (USD Million)<\/p>\n

Table 6 Recombinant DNA Technology Market, By Application, 2017–2023, (USD Million)<\/p>\n

…Continued<\/strong><\/p>\n

LIST OF FIGURES<\/p>\n

Figure 1 Research Process<\/p>\n

Figure 2 Segmentation Of The Recombinant DNA Technology Market<\/p>\n

Figure 3 Segmentation Market Dynamics For The Recombinant DNA Technology Market<\/p>\n

Figure 4 Global Recombinant DNA Technology Market Share, By Product 2016<\/p>\n

Figure 5 Global Recombinant DNA Technology Market Share, By Component 2016<\/p>\n

Figure 6 Global Recombinant DNA Technology Market Share, By Application 2016<\/p>\n

…Continued<\/strong><\/p>\n

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https:\/\/www.marketresearchfuture.com\/reports\/recombinant-dna-technology-market-5845<\/a><\/strong><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR)<\/strong>, we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.<\/p>\n

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.<\/p>\n

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.marketresearchfuture.com\/reports\/recombinant-dna-technology-market-5845<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Recombinant DNA Technology Market Recombinant DNA Technology Market Research Report: By Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food & Agriculture, Health & Disease), End-User (Biotechnology Companies, Pharmaceuticals) \u2013 Forecast to 2023 Recombinant DNA Technology Market Scenario  Market Research … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-506435","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/506435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=506435"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/506435\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=506435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=506435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=506435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}